The reaction of the neutral dithiolene [Pd(Et2timdt)2] (Et2timdt = formally monoreduced diethylimidazolidine-2,4,5-trithione) with an excess of Br2 yielded few crystals of [1(Et) x 2Br](2+)(Br-)2(Br2)3 as a by-product (1(Et) = 4,5,9,10-tetrathiocino-[1,2-b:5,6-b']-1,3,6,8-tetraethyl-diimidazolyl-2,7-dithione); X-ray diffraction analysis showed that this compound represents the first example of a polybromide 2D-network templated by [1(Et) x 2Br](+2) dications, and featuring all the Br-Br distances shorter than those found in solid state bromine.
The tetrabutylammonium (TBA(+)) salts of square-planar monoanionic gold complexes of the unsymmetrically substituted Ar,H-edt(2-) 1,2-dithiolene ligands (Ar,H-edt(2-)=arylethylene-1,2-dithiolato; Ar=phenyl (1(-)), 2-naphthyl (2(-)), and 1-pyrenyl (3(-))) were synthesized and characterized by spectroscopic and electrochemical methods and the corresponding neutral species (1, 2, and 3, respectively) were obtained in CH(2)Cl(2) solution at room temperature by diiodine oxidation. The single-crystal X-ray diffraction structural data collected for (TBA(+))(2(-)), supported by DFT theoretical calculations, are consistent with the ene-1,2-dithiolate form of the ligand and the Au(III) oxidation state. All complexes feature intense near-IR absorptions (at about 1.5 microm) in their neutral states and Vis-emitting properties in the 400-550 nm range, the energy of which is controlled by the charge of the complex in the case of the 3(-)/3 couple. The spectroscopic and electrochemical features of 1(x-) and 2(x-) (x=0, 1), both in their cis and trans conformations, were investigated by means of DFT and time-dependent (TD) DFT calculations.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.